Why Non-Invasive Pain Management Devices Are Gaining Ground In India
How Technology Is Reshaping The Pain Management Devices Market
Pain management is undergoing a global structural shift. As concerns grow around long-term medication use, dependency, and invasive interventions, patients and clinicians are increasingly turning to safer, technology-driven alternatives. Reflecting this shift, the global pain management therapeutics market is valued at USD 85.2 billion in 2024 and is projected to reach USD 130.8 billion by 2033, growing at a steady CAGR of 5%. Devices, digital therapies, and non-invasive solutions are emerging as key growth drivers within this expanding ecosystem.
India mirrors this momentum even more sharply. The country’s pain management devices market is expected to reach USD 336.1 million by 2030, with a projected CAGR of 11.3% between 2025 and 2030, driven by rising musculoskeletal disorders, sedentary lifestyles, sports injuries, and increased acceptance of home-based care.
CURAPOD Entering A High-Momentum Health Tech Segment
Founded in 2022 by Sri Velliyur and Surya Maguluri and backed by Litemed, CURAPOD was developed to address this precise shift in consumer wellness needs. Built as India’s first personalised non-invasive pain management device, Curapod is designed for everyday users dealing with recurring or persistent musculoskeletal pain who are seeking clinically credible, drug-free relief.
Manufactured in India and registered with both the Central Drugs Standard Control Organization (CDSCO) and the FDA, Curapod brings together local engineering capability and global regulatory standards, positioning it as a trusted solution in a fast-evolving category.
To read the full article, please log on to the link below:
https://www.magzter.com/IN/SANBROS-MEDIA/Urban-Melange/Fashion/All-Issues